en · de · es
cardarine-notes.peptides1004.com › Guide › Cardarine As Investigational Pparδ Agonist — Complete Guide

Cardarine As Investigational Pparδ Agonist — Complete Guide

By Editorial Desk · published 2025-10-03 · last reviewed 2025-11-18 · Guide

A practical reference on Nuclear receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-11-18 and is reviewed periodically as new material appears.

Cardarine as Investigational PPARδ Agonist

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Mechanism and Research Context

GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.

Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.

Cardarine at a glance

PropertyValueNotes
Common synonymsGW501516, GW-501516, GW 501516, endurobolNames vary in research and anti-doping documents.
Chemical classSynthetic PPARδ agonistSmall-molecule nuclear receptor ligand.
CAS Registry Number317318-70-0Identifier commonly associated with GW501516.
AppearanceWhite to off-white powderTypical for purified research material.
SolubilityLow in water; soluble in DMSO and ethanolOrganic solvents are common for laboratory stock solutions.

Mechanism and Laboratory Detection

GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.

Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.

Related pages on this site

Regulatory Status and Detection Context

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Background from the literature

== Biography == Sakel was born to a Jewish family on June 6, 1900, in Nadvirna (Nadwórna), in the former Austria-Hungary Empire (now Ukraine), which was part of Poland between the world wars. Sakel studied Medicine at the University of Vienna from 1919 to 1925, specializing in neurology and neuropsychiatry. From 1927 until 1933 Sakel worked in hospitals in Berlin. In 1933 he became a researcher for the University of Vienna's Neuropsychiatric Clinic. In 1936, after receiving an invitation from Frederick Parsons, a commissioner of mental hygiene, he chose to emigrate from Austria to the United States of America. In the USA, he became an attending physician and researcher at the Harlem Valley State Hospital. Dr. Sakel was the developer of insulin shock therapy from 1927 while a young doctor in Vienna, starting to practice it in 1933. It would become used widely for individuals with schizophrenia and other mental patients. He noted that insulin-induced coma and convulsions, due to the low level of glucose attained in the blood (hypoglycemic crisis), had a short-term appearance of changing the mental state of drug addicts and psychotics, sometimes dramatically. He reported that as many as 88% of his patients improved with insulin shock therapy, but most other people reported more mixed results and it was shown eventually that patient selection had been biased and that it didn't really have any specific benefits and had many risks, adverse effects and fatalities. However, his method was used for many years in mental institutions worldwide.

In the 15th century, Cossack society was described as a federation of independent communities, which often formed local cavalry units and were entirely independent from neighboring states such as Poland, the Grand Duchy of Moscow, and the Crimean Khanate. There are confusing historical reports, according to Mykhailo Hrushevsky, that "the first mention of Cossacks dates back to the 14th century", although that seems indicative of people who were either Turkic or of undefined origin. Hrushevsky states that a deeper intuitive study of the evolution of the Cossacks indicates they may have descended from the long-forgotten Antes, or from groups from the Berlad territory of the Brodnici in present-day Romania, then a part of the Grand Duchy of Halych. There, the Cossacks may have served as self-defence formations, organized to defend against raids conducted by aggressive far-ranging tribes. The first international mention of Cossacks was in 1492, when Crimean Khan Meñli I Giray complained accusingly to Grand Duke of Lithuania Alexander Jagiellon that the Grand Duke's Cossack subjects from Kiev and Cherkasy had pillaged a Crimean Tatar ship. The duke ordered his "Ukrainian" (meaning borderland) officials to investigate, execute the guilty, and give their belongings to the Khan. Sometime in the 16th century, there appeared an old Ukrainian Ballad of Cossack Holota, about a Cossack near Kiliya. In the 16th century Cossack societies evolved into two independent territorial organizations, as well as other smaller, still-detached groups:

Type I: Atresia is restricted to the common bile duct. Type II: Atresia of the common hepatic duct. Type III: Atresia involves the most proximal part of the bile ducts (>95% of all cases). In approximately 10% of cases, other anomalies may be associated with biliary atresia. The most common of these syndromic forms is BASM and might include heart lesions, polysplenia, situs inversus, absent venae cavae, and a preduodenal portal vein. Progressive cirrhosis is associated with signs and symptoms of portal hypertension, such as esophagogastric varix bleeding, hypersplenism, hepatorenal syndrome, and hepatopulmonary syndrome. In an Egyptian study, abnormally high levels of aflatoxin B1 and to a lesser extent aflatoxin B2 was found in liver tissue and blood of all neonates with biliary atresia. Aflatoxins may cause extensive damage to the hepatocytes leading to hepatitis and damage to bile ducts causing inflammation, adhesions and final obstruction of bile ducts. The affected neonates have a genetic detoxification defect that does not allow them to detoxify these aflatoxins timely or effectively. The babies have homozygous deficiency of glutathione S transferase (GST) M1. The aflatoxin damaged liver cells and bile duct cells are removed by neutrophil elastase and by involvement of immune system mediators such as CCL-2 or MCP-1, tumor necrosis factor (TNF), interleukin-6 (IL-6), TGF-beta, endothelin (ET), and nitric oxide (NO). Among these, TGF-beta is the most important pro-fibrogenic cytokine that can be seen in progressive cirrhosis.

Sources: en.wikipedia.org

Further detail

ADP + a phosphoprotein Thus, the two substrates of this enzyme are ATP and a protein, whereas its two products are ADP and phosphoprotein. The systematic name of this enzyme class is ATP:protein phosphotransferase (non-specific).

=== Agricultural feed === A wide variety of agroindustrial waste products can be fermented to use as food for animals, especially ruminants. Fungi have been employed to break down cellulosic wastes to increase protein content and improve in vitro digestibility.

== War period, 1938–1945 == When the committee was outlawed in September 1937, six of its members were deported, its president Amin al-Husayni managed to escape arrest and went into exile in Beirut. Jamal al-Husayni escaped to Syria. Three other members were deported to the Seychelles, and other members moved into voluntary exile in neighbouring countries. Al-Hadi, who was out of the country at the time, was not allowed to return. Membership of the outlawed committee had dwindled to Jamal al-Husayni (acting chairperson), Husayn al-Khalidi (secretary), Ahmed Hilmi Pasha and Emil Ghuri. For all practical purposes, the committee ceased to exist, however, this brought little change in the structure of Arab political life and the Palestinian revolt continued. With the indications of a new European war on the horizon, and in an endeavor to resolve the inter-communal issues in Palestine, the British government proposed in late 1938 a conference in London of the two Palestinian communities. Some Arab leaders welcomed the proposed London Conference but indicated that the British would need to deal with the disbanded Arab Higher Committee and with Amin al-Husayni. On 23 November 1938, the Colonial Secretary, Malcolm MacDonald, repeated his refusal to allow Amin al-Husayni to be a delegate, but was willing to allow the five Palestinian leaders held in the Seychelles to take part in the conference.

Sources: en.wikipedia.org

Background from the literature

Note that the elasticity of coiled springs comes from shear modulus, not Young's modulus. When a spring is stretched, its wire's length doesn't change, but its shape does. This is why only the shear modulus of elasticity is involved in the stretching of a spring.

In what some have called the First Cold War, from Britain's intervention in the Russian Civil War in 1918 to its uneasy alliance with the Soviet Union against the Axis powers in 1941, British distrust of the revolutionary and regicidal Bolsheviks resulted in domestic, foreign, and colonial policies aimed at resisting the spread of communism. This conflict after 1945 took on new battlefields, new weapons, new players, and a greater intensity, but it was still fundamentally a conflict against Soviet imperialism (real and imagined). The idea of long-term continuity is a minority scholarly view that has been challenged. Frank Ninkovich writes:

== Awards and decorations == For his commitment in Asian countries Prof. Rode has received many awards, amongst others the Honorary Doctorate Degree in Sciences of the Chulalongkorn University, Bangkok (1995), the Honorary Doctorate Degree in Sciences of the King Mongkut’s Institute of Technology, Ladkrabang, Bangkok (1998) and the Honorary Doctorate Degree in Sciences of the Gadjah Mada University, Yogyakarta, Indonesia (2000). In 2007 the King of Thailand, awarded Prof. Rode with the Knight Grand Cross (First Class), the Most Noble Order of the Crown of Thailand, for his activities and achievements to intensify the European-Asian scientific collaborations. In 2008 the Comenius University Bratislava awarded him an Honorary Doctorate Degree for his pioneer work in quantum chemistry studies of molecule and super molecule systems of ion solvation and molecular modelling of biomolecules and medicaments. In 2014 he was appointed Honorary President of ASEA-UNINET. Overview most important Awards and Decorations:

=== Upstanders === In September 2016, Starbucks announced a debut of its first-ever original content series called "Upstanders", which aimed to be inspirational. The series featured podcasts, written word, and video, and was distributed via the Starbucks mobile app, online, and through the company's in-store digital network.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.

Is cardarine a steroid?

No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.

Why was cardarine not developed further?

Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.

How does cardarine work in the body?

It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.

Network